www.canadianrxpharmacy.org
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Tamoxifen - Nolvadex, Arimidex, Colcrys, Desogen, Estrace, Evista, Femara, Premarin, Yasmin
$0.87
Buy now!
Generic Arimidex
Generic Arimidex is used for treating breast cancer in women who have been through menopause, including women with disease progression after tamoxifen therapy.
$8.75
Buy now!
Generic Colcrys
Generic Colcrys is used for treating and preventing pain associated with gouty arthritis.
$0.74
Buy now!
$0.95
Buy now!
Generic Estrace
Generic Estrace is used for treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer.
$0.84
Buy now!
Generic Evista
Treating and preventing osteoporosis (bone thinning) in women past menopause.
$1.31
Buy now!
Generic Femara
Generic Femara is used for primarily treating certain kinds of breast cancer in women past menopause.
$3.89
Buy now!
Generic Premarin
Treating symptoms of advanced breast cancer in selected men and women; treating or preventing a variety of symptoms...
$1.73
Buy now!
$3.00
Buy now!
Choose Your language:
- Testimonials
-
You have been fabulous to work with and I will clearly recommend your service and use it again myself.
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- DARA BioSciences Reports Financial Results for the First Quarter 2012 and ... - MarketWatch (press release)
- DARA BioSciences Reports Financial Results for the First Quarter 2012 and
- MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
- MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth
- NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - MarketWatch (press release)
- NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayMarketWatch (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer
- AQUA® Technology Uses Extend Beyond Protein: Effective measurement of ... - Sacramento Bee
- AQUA® Technology Uses Extend Beyond Protein: Effective measurement of
- The Downside of Chemoprevention for Breast Cancer - Medscape
- The Downside of Chemoprevention for Breast CancerMedscapeIn this study, both tamoxifen and raloxifene were shown to be effective in reducing breast cancer risk
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
